{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:05:26Z","timestamp":1789142726879,"version":"build-2803163510"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibromyalgia is a chronic rheumatic disease of unknown aetiology, highly disabling and mainly affecting women. The aim of our work is to estimate, on a national scale, the economic impact of this disease on the employment of patients and non-professional (informal) care dimension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Survey on Disabilities, Autonomy and Dependency carried out in Spain in 2020\/21 was used to obtain information on disabled individuals with AD and their informal caregivers. Six estimation scenarios were defined as base case, depending on whether the maximum daily informal caregiving time was censored or not, and on the approach chosen for the valuation of informal caregiving time (contingent valuation and replacement time). Another six conservative scenarios were developed using the minimum wage for the estimation of labour losses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our estimates range from 2,443.6 (willingness to pay, censored informal care time) to 7,164.8 million euros (replacement cost, uncensored informal care time) (base year 2021). Multivariate analyses identified that the degree of dependency of the person suffering from fibromyalgia is the main explanatory variable for both the probability of being employed and the time spent in informal care. Conservative scenarios estimates range from 1,807 to 6,528 million euros.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The high economic impact revealed should help to position a health problem that is relatively unknown in society and for which there are significant research and care gaps to be filled.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13561-024-00527-1","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T21:01:39Z","timestamp":1720818099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Social costs associated with fibromyalgia in Spain"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-0307","authenticated-orcid":false,"given":"J","family":"Oliva-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7701-0934","authenticated-orcid":false,"given":"C","family":"Vilaplana-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"issue":"7","key":"527_CR1","first-page":"1577","volume":"26","author":"KP White","year":"1999","unstructured":"White KP, Speechley M, Harth M, Ostbye T. The London fibromyalgia epidemiology study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol. 1999;26(7):1577\u201385.","journal-title":"J Rheumatol"},{"issue":"8","key":"527_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","volume":"67","author":"LM Arnold","year":"2006","unstructured":"Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006;67(8):1219\u201325.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"527_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/art.23828","volume":"59","author":"SM Bigatti","year":"2008","unstructured":"Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 2008;59(7):961\u20137.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"527_CR4","first-page":"519","volume":"26","author":"AJ Mas","year":"2008","unstructured":"Mas AJ, Carmona L, Valverde M, Ribas B, EPISER Study Group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008;26(4):519\u201326.","journal-title":"Clin Exp Rheumatol."},{"key":"527_CR5","doi-asserted-by":"crossref","first-page":"215013192210941","DOI":"10.1177\/21501319221094169","volume":"13","author":"G SauchValma\u00f1a","year":"2022","unstructured":"SauchValma\u00f1a G, Mir\u00f3 Catalina Q, Vidal-Alaball J. Prevalence and incidence of patients with fibromyalgia in Catalonia between 2010 and 2017: a descriptive observational study. J Prim Care Commun Health. 2022;13:21501319221094170.","journal-title":"J Prim Care Commun Health."},{"issue":"5","key":"527_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.reuma.2017.02.008","volume":"14","author":"MS El-Rabbat","year":"2018","unstructured":"El-Rabbat MS, Mahmoud NK, Gheita TA. Clinical significance of fibromyalgia syndrome in different rheumatic diseases: Relation to disease activity and quality of life. Reumatol Clin (Engl Ed). 2018;14(5):285\u20139.","journal-title":"Reumatol Clin (Engl Ed)."},{"issue":"4","key":"527_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","volume":"57","author":"AP Marques","year":"2017","unstructured":"Marques AP, Santo ASDE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356\u201363.","journal-title":"Rev Bras Reumatol Engl Ed."},{"issue":"9","key":"527_CR8","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","volume":"37","author":"F Heidari","year":"2017","unstructured":"Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37(9):1527\u201339.","journal-title":"Rheumatol Int"},{"issue":"7","key":"527_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2165\/11313650-000000000-00000","volume":"27","author":"L Annemans","year":"2009","unstructured":"Annemans L, Le Lay K, Taieb C. Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics. 2009;27(7):547\u201359.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"527_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1477-7525-9-71","volume":"22","author":"C Schaefer","year":"2011","unstructured":"Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011;22(9):71.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"527_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/24740527.2020.1820858","volume":"4","author":"K Mukhida","year":"2020","unstructured":"Mukhida K, Carroll W, Arseneault R. Does work have to be so painful? A review of the literature examining the effects of fibromyalgia on the working experience from the patient perspective. Can J Pain. 2020;4(1):268\u201386.","journal-title":"Can J Pain"},{"issue":"15","key":"527_CR12","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3109\/09638288.2011.641658","volume":"34","author":"C Rakovski","year":"2012","unstructured":"Rakovski C, Zettel-Watson L, Rutledge D. Association of employment and working conditions with physical and mental health symptoms for people with fibromyalgia. Disabil Rehabil. 2012;34(15):1277\u201383.","journal-title":"Disabil Rehabil"},{"issue":"3","key":"527_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s41927-019-0089-0","volume":"26","author":"F Laroche","year":"2019","unstructured":"Laroche F, Azoulay D, Trouvin AP, Coste J, Perrot S. Fibromyalgia in the workplace: risk factors for sick leave are related to professional context rather than fibromyalgia characteristics- a French national survey of 955 patients. BMC Rheumatol. 2019;26(3):44.","journal-title":"BMC Rheumatol"},{"issue":"3","key":"527_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/1573397113666170502152955","volume":"13","author":"A Palstam","year":"2017","unstructured":"Palstam A, Mannerkorpi K. Work Ability in Fibromyalgia: An Update in the 21st Century. Curr Rheumatol Rev. 2017;13(3):180\u20137.","journal-title":"Curr Rheumatol Rev"},{"issue":"14","key":"527_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12913-014-0513-5","volume":"11","author":"A Collado","year":"2014","unstructured":"Collado A, Gomez E, Coscolla R, Sunyol R, Sol\u00e9 E, Rivera J, Altarriba E, Carbonell J, Castells X. Work, family and social environment in patients with Fibromyalgia in Spain: an epidemiological study: EPIFFAC study. BMC Health Serv Res. 2014;11(14):513.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"527_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40273-014-0137-y","volume":"32","author":"TL Skaer","year":"2014","unstructured":"Skaer TL. Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics. 2014;32(5):457\u201366.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"527_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/imj.13135","volume":"46","author":"EK Guymer","year":"2016","unstructured":"Guymer EK, Littlejohn GO, Brand CK, Kwiatek RA. Fibromyalgia onset has a high impact on work ability in Australians. Intern Med J. 2016;46(9):1069\u201374.","journal-title":"Intern Med J"},{"issue":"1","key":"527_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1001\/jamainternmed.2020.5651","volume":"181","author":"RO Mascarenhas","year":"2021","unstructured":"Mascarenhas RO, Souza MB, Oliveira MX, Lacerda AC, Mendon\u00e7a VA, Henschke N, Oliveira VC. Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2021;181(1):104\u201312.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"527_CR19","first-page":"1151","volume":"40","author":"F Salaffi","year":"2022","unstructured":"Salaffi F, Di Carlo M, Farah S, Mariani C, Fulginei S, Martino GP, Sarzi-Puttini P. A cross-sectional research on female workers examining the loss of productivity caused by mild, moderate and severe fibromyalgia. Clin Exp Rheumatol. 2022;40(6):1151\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"527_CR20","doi-asserted-by":"publisher","first-page":"e0273667","DOI":"10.1371\/journal.pone.0273667","volume":"17","author":"MA Espinoza","year":"2022","unstructured":"Espinoza MA, Bilbeny N, Abbott T, Carcamo C, Zitko P, Zamorano P, Balmaceda C. Cost analysis of chronic pain due to musculoskeletal disorders in Chile. PLoS ONE. 2022;17(10):e0273667. https:\/\/doi.org\/10.1371\/journal.pone.0273667. PMID: 36301984; PMCID: PMC9612497.","journal-title":"PLoS ONE"},{"issue":"3","key":"527_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/msc.1039","volume":"11","author":"DA Marcus","year":"2012","unstructured":"Marcus DA, Richards KL, Chambers JF, Bhowmick A. Fibromyalgia family and relationship impact exploratory survey. Musculoskelet Care. 2012;11(3):125\u201334.","journal-title":"Musculoskelet Care"},{"issue":"2","key":"527_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2165\/11535250-000000000-00000","volume":"9","author":"A Winkelmann","year":"2011","unstructured":"Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011;9(2):125\u201336.","journal-title":"Appl Health Econ Health Policy"},{"issue":"13","key":"527_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2474-13-22","volume":"17","author":"S Perrot","year":"2012","unstructured":"Perrot S, Schaefer C, Knight T, Hufstader M, Chandran AB, Zlateva G. Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains. BMC Musculoskelet Disord. 2012;17(13):22.","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"527_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/1756-185X.14094","volume":"24","author":"F Gharibpoor","year":"2021","unstructured":"Gharibpoor F, Nasrollahzadeh E, Ghavidel-Parsa B, Ghaffari ME, Bidari A. High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study. Int J Rheum Dis. 2021;24(5):671\u201380.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"527_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/art.21700","volume":"55","author":"JW Reich","year":"2006","unstructured":"Reich JW, Olmsted ME, van Puymbroeck CM. Illness uncertainty, partner caregiver burden and support, and relationship satisfaction in fibromyalgia and osteoarthritis patients. Arthritis Rheum. 2006;55(1):86\u201393.","journal-title":"Arthritis Rheum"},{"issue":"17","key":"527_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12891-016-1027-6","volume":"16","author":"A Lacasse","year":"2016","unstructured":"Lacasse A, Bourgault P, Choini\u00e8re M. Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskelet Disord. 2016;16(17):168.","journal-title":"BMC Musculoskelet Disord"},{"issue":"5 Suppl 56","key":"527_CR27","first-page":"S39","volume":"27","author":"J Rivera","year":"2009","unstructured":"Rivera J, Rejas J, Esteve-Vives J, Vallejo MA, Groupo ICAF. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain. Clin Exp Rheumatol. 2009;27(5 Suppl 56):S39-45.","journal-title":"Clin Exp Rheumatol."},{"issue":"6 Suppl 74","key":"527_CR28","first-page":"31","volume":"30","author":"J Rivera","year":"2012","unstructured":"Rivera J, Rejas-Guti\u00e9rrez J, Vallejo MA, Esteve-Vives J, De Salas-Cansado M, ICAF Group. Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice. Clin Exp Rheumatol. 2012;30(6 Suppl 74):31\u20138.","journal-title":"Clin Exp Rheumatol."},{"issue":"6","key":"527_CR29","first-page":"415","volume":"18","author":"A Chandran","year":"2012","unstructured":"Chandran A, Schaefer C, Ryan K, Baik R, McNett M, Zlateva G. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm. 2012;18(6):415\u201326.","journal-title":"J Manag Care Pharm."},{"key":"527_CR30","doi-asserted-by":"crossref","unstructured":"Vervoort VM, Vriezekolk JE, Olde Hartman TC, Cats HA, van Helmond T, van der Laan WH, \u2026 van den Ende CH. Cost of illness and illness perceptions in patients with fibromyalgia. Clin Exp Rheumatol 2016;34(2 Suppl 96):S74\u2013S82.","DOI":"10.1136\/annrheumdis-2015-eular.2933"},{"issue":"3","key":"527_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/ard.2003.019711","volume":"64","author":"A Boonen","year":"2005","unstructured":"Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, van der Linden S. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis. 2005;64(3):396\u2013402.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"527_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3344\/kjp.2015.28.3.169","volume":"28","author":"B Ghavidel-Parsa","year":"2015","unstructured":"Ghavidel-Parsa B, Bidari A, Amir Maafi A, Ghalebaghi B. The Iceberg nature of fibromyalgia burden: the clinical and economic aspects. Korean J Pain. 2015;28(3):169\u201376. https:\/\/doi.org\/10.3344\/kjp.2015.28.3.169. Epub 2015 Jul 1. PMID: 26175876; PMCID: PMC4500780.","journal-title":"Korean J Pain."},{"key":"527_CR33","volume-title":"The demand for health: a theoretical and empirical investigation","author":"M Grossman","year":"1972","unstructured":"Grossman M. The demand for health: a theoretical and empirical investigation. New York: Columbia University Press; 1972."},{"key":"527_CR34","volume-title":"Handbook of health economics","author":"M Grossman","year":"2000","unstructured":"Grossman M. The human capital model of the demand for health. In: Culyer Ayn JP, editor. Handbook of health economics. Amsterdam: North-Holland-Springer-Verlag; 2000."},{"issue":"4","key":"527_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40273-014-0132-3","volume":"32","author":"M Krol","year":"2014","unstructured":"Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32(4):335\u201344.","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"527_CR36","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40273-013-0104-z","volume":"31","author":"RJ Hoefman","year":"2013","unstructured":"Hoefman RJ, van Exel J, Brouwer W. How to include informal care in economic evaluations. Pharmacoeconomics. 2013;31(12):1105\u201319. https:\/\/doi.org\/10.1007\/s40273-013-0104-z. PMID: 24218135.","journal-title":"Pharmacoeconomics"},{"key":"527_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10198-003-0189-y","volume":"5","author":"B van den Berg","year":"2004","unstructured":"van den Berg B, Brouwer WBF, Koopmanschap MA. Economic valuation of informal care. HEPAC. 2004;5:36\u201345. https:\/\/doi.org\/10.1007\/s10198-003-0189-y.","journal-title":"HEPAC"},{"issue":"6","key":"527_CR38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jval.2015.05.001","volume":"18","author":"S Garrido-Garc\u00eda","year":"2015","unstructured":"Garrido-Garc\u00eda S, S\u00e1nchez-Mart\u00ednez FI, Abell\u00e1n-Perpi\u00f1\u00e1n JM, van Exel J. Monetary valuation of informal care based on carers\u2019 and noncarers\u2019 preferences. Value Health. 2015;18(6):832\u201340. https:\/\/doi.org\/10.1016\/j.jval.2015.05.001.","journal-title":"Value Health"},{"issue":"5","key":"527_CR39","doi-asserted-by":"publisher","first-page":"e0217016","DOI":"10.1371\/journal.pone.0217016","volume":"14","author":"J Oliva-Moreno","year":"2019","unstructured":"Oliva-Moreno J, Pe\u00f1a-Longobardo LM, Garc\u00eda-Moch\u00f3n L, Del R\u00edo Lozano M, Mosquera Metcalfe I, Garc\u00eda-Calvente MDM. The economic value of time of informal care and its determinants (The CUIDARSE Study). PLoS ONE. 2019;14(5):e0217016. https:\/\/doi.org\/10.1371\/journal.pone.0217016.","journal-title":"PLoS ONE"},{"issue":"3","key":"527_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40273-016-0468-y","volume":"35","author":"J Oliva-Moreno","year":"2017","unstructured":"Oliva-Moreno J, Trapero-Bertran M, Pe\u00f1a-Longobardo LM, Del Pozo-Rubio R. The valuation of informal care in cost-of-illness studies: a systematic review. Pharmacoeconomics. 2017;35(3):331\u201345. https:\/\/doi.org\/10.1007\/s40273-016-0468-y. PMID: 27848219.","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"527_CR41","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s40273-021-01053-2","volume":"39","author":"S Urwin","year":"2021","unstructured":"Urwin S, Lau YS, Grande G, Sutton M. The challenges of measuring informal care time: a review of the literature. Pharmacoeconomics. 2021;39(11):1209\u201323. https:\/\/doi.org\/10.1007\/s40273-021-01053-2. Epub 2021 Jul 29. PMID: 34324174; PMCID: PMC8516777.","journal-title":"Pharmacoeconomics."},{"key":"527_CR42","first-page":"21","volume":"2","author":"LC Hamilton","year":"1991","unstructured":"Hamilton LC. How robust is robust regression? Stata Technical Bulletin. 1991;2:21\u20136.","journal-title":"Stata Technical Bulletin"},{"key":"527_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1214\/aoms\/1177703732","volume":"35","author":"PJ Huber","year":"1964","unstructured":"Huber PJ. Robust estimation of a location parameter. Ann Math Stat. 1964;35:73\u2013101.","journal-title":"Ann Math Stat"},{"key":"527_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/00401706.1974.10489171","volume":"16","author":"AE Beaton","year":"1974","unstructured":"Beaton AE, Tukey JW. The fitting of power series, meaning polynomials, illustrated on band-spectroscopic data. Technometrics. 1974;16:147\u201385.","journal-title":"Technometrics"},{"key":"527_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/00031305.1988.10475548","volume":"42","author":"JO Street","year":"1988","unstructured":"Street JO, Carroll RJ, Ruppert D. A note on computing robust regression estimates via iteratively reweighted least squares. Am Stat. 1988;42:152\u20134.","journal-title":"Am Stat"},{"issue":"6","key":"527_CR46","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jhealeco.2004.04.008","volume":"23","author":"CH Van Houtven","year":"2004","unstructured":"Van Houtven CH, Norton EC. Informal care and health care use of older adults. J Health Econ. 2004;23(6):1159\u201380.","journal-title":"J Health Econ"},{"key":"527_CR47","doi-asserted-by":"publisher","first-page":"jrm12361","DOI":"10.2340\/jrm.v55.12361","volume":"55","author":"VM Arfuch","year":"2023","unstructured":"Arfuch VM, Aguilar Mart\u00edn C, Berenguera A, CaballolAngelats R, Gon\u00e7alves AQ, Carrasco-Querol N, Gonz\u00e1lez Serra G, Sancho Sol MC, Fust\u00e9Anguera I, Friberg E, Pettersson E, Casajuana M. Cost-utility of a multicomponent intervention for fibromyalgia versus usual care: a pragmatic randomised controlled trial. J Rehabil Med. 2023;55:jrm12361. https:\/\/doi.org\/10.2340\/jrm.v55.12361.","journal-title":"J Rehabil Med."},{"issue":"1","key":"527_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4078\/jrd.2022.29.1.4","volume":"29","author":"JH Kang","year":"2022","unstructured":"Kang JH, Choi SE, Park DJ, Lee SS. Disentangling Diagnosis and Management of Fibromyalgia. J Rheum Dis. 2022;29(1):4\u201313. https:\/\/doi.org\/10.4078\/jrd.2022.29.1.4. PMID: 37476701; PMCID: PMC10324920.","journal-title":"J Rheum Dis"},{"issue":"19","key":"527_CR49","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3109\/09638288.2012.748842","volume":"35","author":"A Palstam","year":"2013","unstructured":"Palstam A, Gard G, Mannerkorpi K. Factors promoting sustainable work in women with fibromyalgia. Disabil Rehabil. 2013;35(19):1622\u20139.","journal-title":"Disabil Rehabil"},{"key":"527_CR50","doi-asserted-by":"publisher","first-page":"e0138024","DOI":"10.1371\/journal.pone.0138024","volume":"10","author":"B Walitt","year":"2015","unstructured":"Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS ONE. 2015;10:e0138024.","journal-title":"PLoS ONE"},{"issue":"1","key":"527_CR51","doi-asserted-by":"publisher","first-page":"e003904","DOI":"10.1136\/rmdopen-2023-003904","volume":"10","author":"K Amris","year":"2024","unstructured":"Amris K, Ibsen R, Duhn PH, Olsen J, Lolk K, Kjellberg J, Kristensen LE. Health inequities and societal costs for patients with fibromyalgia and their spouses: a Danish cohort study. RMD Open. 2024;10(1):e003904.","journal-title":"RMD Open"},{"issue":"2","key":"527_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1300\/J094v09n02_04","volume":"9","author":"N Kurtze","year":"2001","unstructured":"Kurtze N, Gundersen KT, Sveback S. The impact of perceived physical dysfunction, health habits and affective symptoms on employment status among fibromyalgia support group members. J Musculoskelet Pain. 2001;9(2):39\u201353.","journal-title":"J Musculoskelet Pain"},{"issue":"2","key":"527_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1300\/J094v13n02_05","volume":"13","author":"CS Burckhardt","year":"2005","unstructured":"Burckhardt CS, Liedberg GM, Henriksson CM, Kendall S. The impact of fibromyalgia on employment status of newly-diagnosed young women: a pilot study. J Musculoskelatal Pain. 2005;13(2):31\u201341.","journal-title":"J Musculoskelatal Pain"},{"issue":"4","key":"527_CR54","first-page":"199","volume":"13","author":"AW Al-Allaf","year":"2007","unstructured":"Al-Allaf AW. Work disability and health system utilization in patients with fibromyalgia syndrome. JCR: J Clin Rheumatol. 2007;13(4):199\u2013201.","journal-title":"JCR: J Clin Rheumatol"},{"issue":"5","key":"527_CR55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3899\/jrheum.151041","volume":"43","author":"M-A Fitzcharles","year":"2016","unstructured":"Fitzcharles M-A, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y. Disability in fibromyalgia associates with symptom severity and occupation characteristics. J Rheumatol. 2016;43(5):931\u20136.","journal-title":"J Rheumatol"},{"issue":"9","key":"527_CR56","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/acr.22305","volume":"66","author":"F Wolfe","year":"2014","unstructured":"Wolfe F, Walitt BT, Katz RS, H\u00e4user W. Social security work disability and its predictors in patients with fibromyalgia. Arthritis Care Res. 2014;66(9):1354\u201363.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"527_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2474-13-96","volume":"13","author":"K Mannerkorpi","year":"2012","unstructured":"Mannerkorpi K, Gard G. Hinders for continued work among persons with fibromyalgia. BMC Musculoskelet Disord. 2012;13(1):96.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"527_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/msc.162","volume":"8","author":"M Sallinen","year":"2010","unstructured":"Sallinen M, Kukkurainen ML, Peltokallio L, Mikkelsson M. Women\u2019s narratives on experiences of work ability and functioning in fibromyalgia. Musculoskelet Care. 2010;8(1):18\u201326.","journal-title":"Musculoskelet Care"},{"issue":"4","key":"527_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.aprim.2014.06.002","volume":"47","author":"E Briones-Vozmediano","year":"2015","unstructured":"Briones-Vozmediano E, Ronda-P\u00e9rez E, Vives-Cases C. Percepciones de pacientes con fibromialgia sobre el impacto de la enfermedad en el \u00e1mbito laboral [Fibromyalgia patients\u2019 perceptions of the impact of the disease in the workplace]. Aten Primaria. 2015;47(4):205\u201312.","journal-title":"Aten Primaria"},{"issue":"6","key":"527_CR60","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jbspin.2019.04.012","volume":"86","author":"F Laroche","year":"2019","unstructured":"Laroche F, Gu\u00e9rin J, Coste J, Trouvin AP, Perrot S. Importance of feelings of injustice in fibromyalgia, large internet survey on experiences of 4516 French patients. Joint Bone Spine. 2019;86(6):808\u201310.","journal-title":"Joint Bone Spine"},{"key":"527_CR61","unstructured":"P\u00e9rez JLM, Insua BDML. Secuelas irreversibles y declaraci\u00f3n de incapacidad permanente absoluta en caso de fibromialgia: especial referencia a la finalidad del recurso de suplicaci\u00f3n para la revisi\u00f3n de los hechos probados: STSJ de Castilla y Le\u00f3n, Sala Social, de 22 de febrero de 2019 (recurso suplicaci\u00f3n n\u00fam. 22\/2019). Revista de Jurisprudencia Laboral (RJL). 2019(2):11."},{"issue":"3","key":"527_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12062-015-9116-0","volume":"8","author":"JM Bauer","year":"2015","unstructured":"Bauer JM, Sousa-Poza A. Impacts of informal caregiving on caregiver employment, health, and family. J Popul Ageing. 2015;8(3):113\u201345.","journal-title":"J Popul Ageing"},{"key":"527_CR63","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.ehb.2023.101264","volume":"50","author":"LM Pe\u00f1a-Longobardo","year":"2023","unstructured":"Pe\u00f1a-Longobardo LM, Rodr\u00edguez-S\u00e1nchez B, Oliva J. Does becoming an informal caregiver make your health worse? A longitudinal analysis across Europe. Econ Hum Biol. 2023;50:101264. https:\/\/doi.org\/10.1016\/j.ehb.2023.101264. Epub 2023 Jun 13 PMID: 37364512.","journal-title":"Econ Hum Biol"},{"key":"527_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113562","volume":"269","author":"J Bom","year":"2021","unstructured":"Bom J, St\u00f6ckel J. Is the grass greener on the other side? The health impact of providing informal care in the UK and the Netherlands. Soc Sci Med. 2021;269: 113562.","journal-title":"Soc Sci Med"},{"issue":"9","key":"527_CR65","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s40273-023-01283-6","volume":"41","author":"SA Keramat","year":"2023","unstructured":"Keramat SA, Hashmi R, Aregbeshola BS, Comans T. Informal Caregiving Provision for Disabled or Elderly in the Families and Work Productivity: Evidence from 11 Waves of an Australian Population-Based Cohort. Pharmacoeconomics. 2023;41(9):1117\u201336.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"527_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40273-018-0730-6","volume":"37","author":"WB Brouwer","year":"2019","unstructured":"Brouwer WB. The inclusion of spillover effects in economic evaluations: not an optional extra. Pharmacoeconomics. 2019;37(4):451\u20136.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"527_CR67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s40273-019-00782-9","volume":"37","author":"SD Grosse","year":"2019","unstructured":"Grosse SD, Pike J, Soelaeman R, Tilford JM. Quantifying family spillover effects in economic evaluations: measurement and valuation of informal care time. Pharmacoeconomics. 2019;37(4):461\u201373.","journal-title":"Pharmacoeconomics"},{"issue":"18","key":"527_CR68","doi-asserted-by":"publisher","first-page":"e33643","DOI":"10.1097\/MD.0000000000033643","volume":"102","author":"MJ Cheong","year":"2023","unstructured":"Cheong MJ, Chung CH, Lee CH, Lee MS, Ha WB, Lee JH, Kang HW. Improving quality of life for a patient with fibromyalgia and their caregiver: A protocol for the application of the integrative medical service model. Medicine (Baltimore). 2023;102(18):e33643.","journal-title":"Medicine (Baltimore)"},{"issue":"20","key":"527_CR69","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1080\/09638288.2021.1948620","volume":"44","author":"P Montes\u00f3-Curto","year":"2022","unstructured":"Montes\u00f3-Curto P, Cub\u00ed-Guillen MT, Ll\u00e0dser Navarro AN, Puig Llobet M, Toussaint L. Family perceptions and experiences of living with patients with fibromyalgia syndrome. Disabil Rehabil. 2022;44(20):5855\u201362.","journal-title":"Disabil Rehabil"},{"key":"527_CR70","doi-asserted-by":"crossref","unstructured":"Costa-Font, J., Jim\u00e9nez-Mart\u00edn, S., Vilaplana-Prieto, C. & Viola, A. Universalizing the Access to Long-term Care: Evidence from Spain. NBER WP 31925 (2023).Universalizing the Access to Long-term Care: Evidence from Spain | NBER","DOI":"10.3386\/w31825"},{"issue":"10","key":"527_CR71","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.healthpol.2016.08.012","volume":"120","author":"LM Pe\u00f1a-Longobardo","year":"2016","unstructured":"Pe\u00f1a-Longobardo LM, Oliva-Moreno J, Garc\u00eda-Armesto S, Hern\u00e1ndez-Quevedo C. The Spanish long-term care system in transition: ten years since the 2006 dependency act. Health Policy. 2016;120(10):1177\u201382. https:\/\/doi.org\/10.1016\/j.healthpol.2016.08.012.","journal-title":"Health Policy"},{"issue":"10","key":"527_CR72","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.34172\/ijhpm.2021.149","volume":"11","author":"LM Pe\u00f1a-Longobardo","year":"2022","unstructured":"Pe\u00f1a-Longobardo LM, Oliva-Moreno J. The economic value of non-professional care: a Europe-wide analysis. Int J Health Policy Manag. 2022;11(10):2272\u201386. https:\/\/doi.org\/10.34172\/ijhpm.2021.149.","journal-title":"Int J Health Policy Manag."},{"key":"527_CR73","unstructured":"Jim\u00e9nez-Mart\u00edn, S. & Viola, A. (2022). Observatorio de dependencia. Cuarto Informe, julio 2022. Studies on the Spanish Economy\u00a0eee2022\u201316, FEDEA. Observatorio de dependencia. Cuarto Informe, julio 2022 (repec.org)"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-024-00527-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13561-024-00527-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-024-00527-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T22:02:16Z","timestamp":1720821736000},"score":1,"resource":{"primary":{"URL":"https:\/\/healtheconomicsreview.biomedcentral.com\/articles\/10.1186\/s13561-024-00527-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s13561-024-00527-1","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not require the approval of any ethics committee, in accordance with Spanish legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We confirm that there are no images or other personal or clinical data of the participants that would require consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}